Related Experiment Video
Updated: Jan 23, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Use of dexmedetomidine as adjunctive therapy for anti-N-methyl-D-aspartate receptor encephalitis
Christopher J Babbitt1, Jean Lake1, Glenn K Levine1
1Pediatric Critical Care, Miller's Children Hospital, Long California, CA, USA.
Insights
Anti-N-methyl-D-aspartate receptor encephalitis, a condition affecting children, presents severe neurological symptoms. This report details the successful use of dexmedetomidine for acute treatment, offering a potential new therapeutic option.
Area of Science:
- Neurology
- Pediatrics
- Pharmacology
Background:
- Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is increasingly diagnosed in pediatric patients.
- The condition necessitates intensive care due to severe central nervous system manifestations.
Observation:
- Patients exhibit agitation, abnormal movements, hypoventilation, seizures, and autonomic instability.
- Current treatment guidelines lack consensus for acute symptom management.
Findings:
- This case report introduces dexmedetomidine as a novel therapeutic agent for anti-NMDAR encephalitis.
- Dexmedetomidine effectively managed the acute neurological symptoms in the presented pediatric case.
Implications:
- Dexmedetomidine shows promise as a safe and effective option for managing anti-NMDAR encephalitis in children.
- Further research is warranted to establish dexmedetomidine's role in clinical practice for this condition.
Abstract:
Anti-N-methyl-D-aspartate receptor encephalitis is a recently discovered disease that is more commonly being diagnosed in children. Patients often require intensive care and assisted ventilation due to agitation, abnormal movements, hypoventilation, seizures and autonomic instability. There is no consensus on which medicines are best suited to acutely treat this constellation of central nervous system symptoms. We present the first case report of using dexmedetomidine to treat this condition.
More Related Videos
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
06:06Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Internal Receptors
Gene Therapy
Receptor-mediated Endocytosis
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
G-protein Coupled Receptors